Acumen Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Acumen Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held virtually on June 3, 2026.
NASDAQ
Acumen Pharmaceuticals has filed a definitive proxy statement related to its upcoming shareholder meeting.
NASDAQ
Acumen Pharmaceuticals announces its 2025 Annual Meeting of Stockholders to be held virtually on June 4, 2025, featuring proposals for director elections and ratification of the independent accounting firm.
NASDAQ
Acumen Pharmaceuticals will hold its annual stockholders meeting on June 4, 2024, to elect directors and ratify the selection of its independent accounting firm.
NASDAQ
DEF 14A: Acumen Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Acumen Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 4, 2024, featuring proposals for director elections and ratification of the independent accounting firm.